Standard
Cardiac Myosin Activator Omecamtiv Mecarbil Improves Left Ventricular Myocardial Deformation in Chronic Heart Failure : The COSMIC-HF Trial. / Biering-Sorensen, Tor; Minamisawa, Masatoshi; Claggett, Brian; Liu, Jiankang; Felker, G. Michael; McMurray, John J. V.; Malik, Fady I.; Abbasi, Siddique; Kurtz, Christopher E.; Teerlink, John R.; Solomon, Scott D.
In:
Circulation: Heart Failure, Vol. 13, No. 12, 008007, 2020.
Research output: Contribution to journal › Letter › Research › peer-review
Harvard
Biering-Sorensen, T, Minamisawa, M, Claggett, B, Liu, J, Felker, GM, McMurray, JJV, Malik, FI, Abbasi, S, Kurtz, CE, Teerlink, JR & Solomon, SD 2020, '
Cardiac Myosin Activator Omecamtiv Mecarbil Improves Left Ventricular Myocardial Deformation in Chronic Heart Failure: The COSMIC-HF Trial',
Circulation: Heart Failure, vol. 13, no. 12, 008007.
https://doi.org/10.1161/CIRCHEARTFAILURE.120.008007
APA
Biering-Sorensen, T., Minamisawa, M., Claggett, B., Liu, J., Felker, G. M., McMurray, J. J. V., Malik, F. I., Abbasi, S., Kurtz, C. E., Teerlink, J. R., & Solomon, S. D. (2020).
Cardiac Myosin Activator Omecamtiv Mecarbil Improves Left Ventricular Myocardial Deformation in Chronic Heart Failure: The COSMIC-HF Trial.
Circulation: Heart Failure,
13(12), [008007].
https://doi.org/10.1161/CIRCHEARTFAILURE.120.008007
Vancouver
Biering-Sorensen T, Minamisawa M, Claggett B, Liu J, Felker GM, McMurray JJV et al.
Cardiac Myosin Activator Omecamtiv Mecarbil Improves Left Ventricular Myocardial Deformation in Chronic Heart Failure: The COSMIC-HF Trial.
Circulation: Heart Failure. 2020;13(12). 008007.
https://doi.org/10.1161/CIRCHEARTFAILURE.120.008007
Author
Biering-Sorensen, Tor ; Minamisawa, Masatoshi ; Claggett, Brian ; Liu, Jiankang ; Felker, G. Michael ; McMurray, John J. V. ; Malik, Fady I. ; Abbasi, Siddique ; Kurtz, Christopher E. ; Teerlink, John R. ; Solomon, Scott D. / Cardiac Myosin Activator Omecamtiv Mecarbil Improves Left Ventricular Myocardial Deformation in Chronic Heart Failure : The COSMIC-HF Trial. In: Circulation: Heart Failure. 2020 ; Vol. 13, No. 12.
Bibtex
@article{12946ba6b52c4cd485f247312bc53c71,
title = "Cardiac Myosin Activator Omecamtiv Mecarbil Improves Left Ventricular Myocardial Deformation in Chronic Heart Failure: The COSMIC-HF Trial",
keywords = "atrial fibrillation, cardiac myosin, echocardiography, heart failure, ventricular remodeling",
author = "Tor Biering-Sorensen and Masatoshi Minamisawa and Brian Claggett and Jiankang Liu and Felker, {G. Michael} and McMurray, {John J. V.} and Malik, {Fady I.} and Siddique Abbasi and Kurtz, {Christopher E.} and Teerlink, {John R.} and Solomon, {Scott D.}",
year = "2020",
doi = "10.1161/CIRCHEARTFAILURE.120.008007",
language = "English",
volume = "13",
journal = "Circulation: Heart Failure",
issn = "1941-3289",
publisher = "Lippincott Williams & Wilkins",
number = "12",
}
RIS
TY - JOUR
T1 - Cardiac Myosin Activator Omecamtiv Mecarbil Improves Left Ventricular Myocardial Deformation in Chronic Heart Failure
T2 - The COSMIC-HF Trial
AU - Biering-Sorensen, Tor
AU - Minamisawa, Masatoshi
AU - Claggett, Brian
AU - Liu, Jiankang
AU - Felker, G. Michael
AU - McMurray, John J. V.
AU - Malik, Fady I.
AU - Abbasi, Siddique
AU - Kurtz, Christopher E.
AU - Teerlink, John R.
AU - Solomon, Scott D.
PY - 2020
Y1 - 2020
KW - atrial fibrillation
KW - cardiac myosin
KW - echocardiography
KW - heart failure
KW - ventricular remodeling
U2 - 10.1161/CIRCHEARTFAILURE.120.008007
DO - 10.1161/CIRCHEARTFAILURE.120.008007
M3 - Letter
C2 - 33176443
VL - 13
JO - Circulation: Heart Failure
JF - Circulation: Heart Failure
SN - 1941-3289
IS - 12
M1 - 008007
ER -